Need a specific person's email?
Browse Actavis (now Allergan)'s employee directory (about 1.3K employees) and reveal verified emails free.
Actavis (now Allergan)'s most common email format is Last_First@allergan.com (ex. Doe_John@allergan.com), used for 63% of allergan.com addresses. Actavis (now Allergan) uses 8 email patterns across 2 domains: allergan.com and actavis.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of allergan.com |
|---|---|---|
| Last_First@allergan.comMost common | Doe_John@allergan.com | |
| First.Last@allergan.com | John.Doe@allergan.com | |
| First_Last@allergan.com | John_Doe@allergan.com | |
| LastFirst@allergan.com | DoeJohn@allergan.com |
| Format | Example | Share of actavis.com |
|---|---|---|
| First.Last@actavis.comMost common | John.Doe@actavis.com | |
| FLast@actavis.com | JDoe@actavis.com | |
| FirstLast@actavis.com | JohnDoe@actavis.com | |
| FiLast@actavis.com | JoDoe@actavis.com |
Browse Actavis (now Allergan)'s employee directory (about 1.3K employees) and reveal verified emails free.
Pharmaceutical ManufacturingDublin, Ireland1001-5000 Employees
Actavis, now known as Allergan, is a global pharmaceutical manufacturer headquartered in Dublin, Ireland. The company has a history of producing eyecare products, including contact lens solutions, and developing aesthetic medical offerings, such as facial fillers. This diversification is reflected in product activity like the JUVÉDERM VOLUX launch, which targets non-surgical cosmetic treatment. Operating in the pharmaceutical manufacturing industry, Allergan has a global footprint tied to its broad product development in eye care and aesthetics. In 2020, Allergan was acquired by AbbVie, a move that integrated its portfolio into a larger multinational biopharmaceutical company.
Most common format
Last_First@allergan.com
Example: Doe_John@allergan.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.